What is PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017?

PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 is Malaysia P.U. (A), cited as P.U. (A) 426 2017, currently marked in force and first recorded in 2017.

Is PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 still in force?

Yes — PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 is currently in force.

When did PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 take effect?

PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 was first recorded in 2017.

How many sections does PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 have?

PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 contains 2 sections.

Where can I read the official version of PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017?

The official text of PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 is published at lom.agc.gov.my.

PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017 (No. 426)

Seksyen 1

Perintah ini bolehlah dinamakan Perintah Racun (Pindaan Jadual Ketiga)

(No. 2) 2017.

Seksyen 2

Pindaan Jadual Ketiga

Jadual

Jadual Ketiga kepada Akta Racun 1952 dipinda—

(a)

dalam perenggan 1—

(i)

dengan memasukkan sebelum butiran “Amfepramone” butiran yang berikut:

“N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide

(APINACA)

N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-

carboxamide (5F-APINACA)”;

(ii)

dengan memasukkan selepas butiran “Amfepramone” butiran yang berikut:

“N- [(1S) - 1-

(Aminocarbonyl) - 2- methylpropyl] - 1-

(cyclohexylmethyl) 1H-indazole- 3- carboxamide

(AB-CHMINACA)”;

P.U. (A) 426 3

(iii)

dengan memasukkan selepas butiran “Clotiazepam” butiran yang berikut:

“N-{[1-

(Cyclohexylmethyl)-1H-indol-3yl]carbonyl}-3-

methyl-L-valinate (MDMB-CHMICA)”;

(iv)

dengan memasukkan selepas butiran “Ethylamphetamine” butiran yang berikut:

“Ethylone (3,4-Methylenedioxy-N-ethylcathinone)

Ethylphenidate”;

(v)

dengan memasukkan selepas butiran “[1-(5-fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl) methanone (AM-2201)” butiran yang berikut:

“[1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-

tetrametylcyclopropyl) methanone (XLR-11)”;

(vi)

dengan memasukkan selepas butiran “Methaqualone” butiran yang berikut:

“Methiopropamine (MPA)

Methoxetamine (MXE)”;

(vii)

dengan memasukkan selepas butiran “3,4

Methylenedioxypyrovalerone (MDPV)” butiran yang berikut:

“4-Methylethcathinone (4-MEC)

Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-

yl]carbonyl}amino)-3- methylbutanoate (5F-AMB)

3-Methylmethcathinone (3-MMC)”;

P.U. (A) 426 4

(viii)

dengan memasukkan selepas butiran “Naphtalen-1-yl-(1-pentyl-

1H-indol-3-yl)methanone (JWH-018)” butiran yang berikut:

“Para-methyl-4-methylaminorex (4,4’-DMAR)”;

(ix)

dengan memasukkan selepas butiran

“Pentazocine”

butiran yang berikut:

“Pentedrone (α-methylaminovalerophenone)”; dan

(x)

dengan memasukkan selepas butiran “Pyrovalerone”

butiran yang berikut:

“α-Pyrrolidinovalerophenone (α-PVP)

Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-

carboxylate (5F-PB-22)”; dan

(b)

dalam perenggan 2, dengan memasukkan selepas butiran “Pethidine”

butiran yang berikut:

“Remifentanil”.

Dibuat 15 November 2017

[KKM.R.600-1/1/56; PN(PU2)172/XV]

DATUK SERI DR. S. SUBRAMANIAM

Menteri Kesihatan

P.U. (A) 426 5

POISONS ACT 1952

POISONS (AMENDMENT OF THIRD SCHEDULE) (NO. 2) ORDER 2017

IN exercise of the powers conferred by subsection 30(2)

of the

Poisons Act 1952 [Act 366], the Minister, after consultation with the Poisons Board, makes the following order:

Citation 1.

This order may be cited as the Poisons (Amendment of Third Schedule)

(No. 2) Order 2017.

Amendment of Third Schedule 2.

The Third Schedule to the Poisons Act 1952 is amended—

(a)

in paragraph 1—

(i)

by inserting before the item “Amfepramone” the following items:

“N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide

(APINACA)

N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-

carboxamide (5F-APINACA)”;

(ii)

by inserting after the item “Amfepramone” the following item:

“N-[(1S)-1-

(Aminocarbonyl)-2-methylpropyl]-1-

(cyclohexylmethyl) 1H-indazole- 3- carboxamide (AB-CHMINACA)”;

P.U. (A) 426 6

(iii)

by inserting after the item “Clotiazepam” the following item:

“N-{[1-

(Cyclohexylmethyl)-1H-indol-3yl]carbonyl}-

3-methyl-L-valinate (MDMB-CHMICA)”;

(iv)

by inserting after the item “Ethylamphetamine” the following items:

“Ethylone (3,4-Methylenedioxy-N-ethylcathinone)

Ethylphenidate”;

(v)

by inserting after the item “[1-(5-fluoropentyl)-1H-indol-3-

yl](naphthalen-1-yl) methanone (AM-2201)” the following item:

“[1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-

tetrametylcyclopropyl) methanone (XLR-11)”;

(vi)

by inserting after the item “Methaqualone” the following items:

“Methiopropamine (MPA)

Methoxetamine (MXE)”;

(vii)

by inserting after the item “3,4–Methylenedioxypyrovalerone

(MDPV)” the following items:

“4-Methylethcathinone (4-MEC)

Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-

yl]carbonyl}amino)-3-methylbutanoate (5F-AMB)

3-Methylmethcathinone (3-MMC)”;

(viii)

by inserting after the item “Naphtalen-1-yl-(1-pentyl-1H-indol-3-

yl)methanone (JWH-018)” the following item:

“Para-methyl-4-methylaminorex (4,4’-DMAR)”;

P.U. (A) 426 7

(ix)

by inserting after the item “Pentazocine” the following item:

“Pentedrone (α-methylaminovalerophenone)”; and

(x)

by inserting after the item “Pyrovalerone” the following items:

“α-Pyrrolidinovalerophenone (α-PVP)

Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-

carboxylate (5F-PB-22)”; and

(b)

in paragraph 2, by inserting after the item “Pethidine” the following item:

“Remifentanil”.

Made 15 November 2017

[KKM.R.600-1/1/56; PN(PU2)172/XV]

DATUK SERI DR. S. SUBRAMANIAM

Minister of Health

PERINTAH RACUN (PINDAAN JADUAL KETIGA) (NO. 2) 2017

About this p.u. (a)

Preamble

Seksyen 1

Seksyen 2

Jadual

Common questions